Related Experiment Video

Updated: May 31, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

[Second-line treatment of advanced renal cell carcinoma after first-line targeted therapy]

Yoshihiko Tomita1

  • 1Dept. of Urology, Yamagata University Faculty of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 17, 2011
PubMed

Insights

Targeted drugs like everolimus improve survival for advanced renal cell carcinoma (RCC) patients after initial treatments. More research is needed on sequencing these targeted therapies for optimal outcomes.

Area of Science:

  • Oncology
  • Pharmacology

Context:

  • Advanced renal cell carcinoma (RCC) treatment landscape.
  • Evolution from cytokine therapy to targeted agents.
  • Need for evidence in second-line treatment settings.

Purpose:

  • To review the efficacy of targeted drugs in advanced RCC.
  • To assess the role of everolimus in second-line therapy.
  • To highlight the need for further research on treatment sequencing.

Summary:

  • Cytokines were historically effective for advanced RCC.
  • Targeted drugs have prolonged patient survival.
  • Everolimus shows efficacy after sunitinib/sorafenib progression.
  • High-quality evidence for second-line targeted therapy is limited.

Impact:

  • Informs clinical decisions for advanced RCC management.
  • Identifies gaps in evidence for second-line treatment strategies.
  • Suggests future research directions for optimizing targeted therapy sequencing.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...